In fact, the Cowen analysts say, the last stock to outperform after its FDA launch was Alexion, the maker of the high-priced orphan drug Soliris, in 2007.
For those investors that can get out of their bunkers to do some stock picking, you might want to go for some high-quality, low-priced dividend stocks that will pay you to own them.